The steep decline in oversight has stalled a number of new drug applications. The agency says it is trying to protect its employees but critics say inspectors should be considered essential workers and do their jobs.
Published: March 9, 2021 at 11:00AM
from NYT Health https://ift.tt/38k5hMH